BTG3 and cancer: Another miRNA, miR20b-5p, which was significantly downregulated by pembrolizumab treatment, was shown in other studies to be highly expressed in LC and targeting B cell translocation gene 3 (BTG3), thus downregulating BTG3 expression and leading to increased proliferation and cancer cell migration [24].